Is intestinal metaplasia of the stomach reversible?
Open Access
- 1 January 2003
- Vol. 52 (1) , 1-4
- https://doi.org/10.1136/gut.52.1.1
Abstract
Intestinal metaplasia (IM) of the stomach is a risk factor in developing intestinal-type gastric cancer and hence the question of reversibility is vital. There is emerging epidemiological evidence that with long term follow up, IM may be reversible although a combination of antioxidant agents and eradication of H pylori may be necessary to achieve this. The pathogenesis of IM is currently being elucidated and it is likely that a combination of bacterial, host, and environmental factors will be shown to lead to IM. In assessing gastric cancer risk, histochemical typing of IM will most probably be replaced by molecular markers.Keywords
This publication has 39 references indexed in Scilit:
- Key molecules in metaplastic gastritis: sequential analysis of CDX1/2 homeobox gene expression.The Esophagus, 2002
- Expression of homeobox gene CDX2 precedes that of CDX1 during the progression of intestinal metaplasiaThe Esophagus, 2002
- Prevalence of Subtypes of Intestinal Metaplasia in the General Population and in Patients with Autoimmune Chronic Atrophic GastritisScandinavian Journal of Gastroenterology, 2002
- Atrophic Gastritis and Intestinal Metaplasia in Japan: Results of a Large Multicenter StudyHelicobacter, 2001
- Effect of Helicobacter pylori eradication on expression of cyclin D2 and p27 in gastric intestinal metaplasiaAlimentary Pharmacology & Therapeutics, 2001
- Genetic factors in the development of gastric precancerous lesions—a role of Helicobacter pylori ?Journal of Physiology-Paris, 2001
- Chemoprevention of Gastric Dysplasia: Randomized Trial of Antioxidant Supplements and Anti-Helicobacter pylori TherapyJNCI Journal of the National Cancer Institute, 2000
- Does Eradication of Helicobacter Pylori Reverse Atrophic Gastritis or Intestinal Metaplasia?Gastroenterology Clinics of North America, 2000
- Gastric Dysplasia and Gastric Cancer: Helicobacter pylori, Serum Vitamin C, and Other Risk FactorsJNCI Journal of the National Cancer Institute, 2000
- Ascorbic acid and intestinal metaplasia in the stomach: a prospective, randomized studyAlimentary Pharmacology & Therapeutics, 2000